• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/35

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

35 Cards in this Set

  • Front
  • Back
193. Dialysis cysts?
a. Cortical and medullary cysts resulting from long-standing dialysis.
194. Simple cysts of kidney?
a. Benign, common (>40% of elderly)
b. Incidental finding.
c. This, nonenhancing, cortical, fluid filled.
195. Medullary cystic disease?
a. Medullary cysts sometimes lead to fibrosis and progressive renal insufficiency with urinary concentrating defects.
b. Ultrasound shows SMALL kidney.
c. Poor prognosis.
196. Mannitol MOA?
a. Osmotic diuretic
b. ↑ tubular fluid osmolarity, producing ↑ urine flow.
197. Clinical use of Mannitol?
a. Shock
b. Drug overdose
c. ↑ ICP or intraocular pressure
198. Mannitol toxicity?
a. Pulmonary oedema
b. Dehydration
199. When is mannitol contraindicated?
a. Anuria
b. CHF.
200. MOA of Acetazolamide?
a. Carbonic anhydrase inhibitor.
b. Causes self-limited NaHCO3 diureses and reduction in total-body HCO3 stores.
201. Clinical use of acetazolamide?
a. Glaucoma
b. Urinary alkalinization
c. Metabolic alkalosis
d. Altitude sickness.
202. Toxicity of acetazolamide?
a. Hyperchloremic metabolic acidosis
b. Neuropathy
c. NH3 toxicity
d. Sulfa allergy.
e. “ACIDazolamide causes ACIDOSIS”.
203. Furosemide MOA?
a. Sulfonamide loop diuretic.
b. Inhibits cotransport of Na-K-2Cl of thick ascending limb.
c. Abolishes hypertonicity of medulla, preventing concentration of urine.
d. ↑ Ca2+ excretion. Loops Lose Calcium.
204. Clinical uses of furosemide?
a. Oedematous states (CHF, cirrhosis, nephrotic syndrome, pulmonary oedema)
b. HTN
c. Hypercalcemia
205. Toxicity of Furosemide?
a. Oto and renal (interstitial nephritis- bc it’s a sulfonamide derivative)
b. Hypokalaemia
c. Allergy (sulfa)!!!!
d. Gout
e. Dehydration
206. Ethacrynic acid MOA?
a. Phenoxyacetic acid derivative (NOT a sulfonamide).
b. Essentially same MOA as furosemide.
207. Clinical use of Ethacrynic acid?
a. Diuresis in pts allergic to sulfa drugs.
208. Tox of ethacrynic acid?
a. Similar to furosemide but can be used in pts w/hyperuricemia and acute gout (never used to treat gout).
209. HCTZ MOA?
a. Inhibits NaCl reabsorption in early distal tubule, reducing diluting capacity of the nephron.
b. ↓ Ca excretion (so retains calcium).
210. Clinical use of HCTZ?
a. HTN
b. CHF
c. Idiopathic hypercalciuria
d. Nephrogenic diabetes insipidus.
211. Tox of HCTZ?
a. Hypokalemic metabolic alkalosis
b. Hyponatremia
c. Hyperglycemia
d. Hyperlipidemia
e. Hyperuricemia
f. Hypercalcemia.
g. Sulfa allergy.
212. K+ sparing diuretics listed (4)?
1. Spironolactone
2. Triamterene
3. Amiloride
4. Eplerone
213. MOA of Spironolactone?
a. Competitive aldosterone receptor antagonist in the cortical collecting tubule.
214. How does the MOA of Triamterene and amiloride differ from Spirinolactone?
a. They act at the same part of the tubule by blocking Na channels in the CCT.
215. Clinical use of spironolactone?
a. Hyperaldosteronism
b. K+ depletion
c. CHF
216. Tox of Spironolactone?
a. Hyperkalemia- arrhythmias
b. Gynecomastia
c. Impotence
217. Effect of all diuretics on Urine NaCl?
a. All diuretics ↑ urine NaCl.
b. Serum NaCl may ↓ as a result.
218. Effect of all diuretics except for K-sparing on urine K+?
a. All ↑ urine K (save for K sparing).
b. Serum K may ↓ as a result.
219. Which diuretics ↓ blood pH (causing acidemia)?
a. Carbonic anhydrase inhibitors- HCO3- reabsorption.
b. K+ sparing aldosterone blockade prevents K+ and H+ secretion.
c. Additionally, hyperkalemia leads to K+ entering all cells (via H+/K+ exchanger in exchange for H+ exiting cells.
220. Which diuretics ↑ pH (causing alkalemia)?
a. Loop diuretics and thiazides cause alkalemia through several mechanisms:
1. Volume contraction: ↑ ATII-> ↑ Na/H+ exchanger in proximal tubule -> ↑ HCO3 (“contraction alkalosis”.
2. K+ loss leads to K+ exiting all cells (via H+/K+ exchanger) in exchange for H+ entering cells.
3. In low K+ state, H+ (rather than k+) is exchanged for Na in cortical collecting tubule, leading to alkalosis and “paradoxical aciduria”.
221. How do Loops ↑ urine Ca?
a. Abolish lumen-positive potential in thick ascending limb-> ↓ paracellular Ca2+ reabsorption -> hypocalcemia and ↑ urinary Ca2+.
222. How do thiazides ↓ urine Ca?
a. Volume depletion -> ↑up-regulation of sodium reabsorption -> enhanced paracellular Ca reabsorption in proximal tubule and LOH.
b. Thiazides also block luminal Na/Cl cotransport in distal tubule ->↑ Na+ gradient -> ↑ interstitial Na/Ca exchange -> hypercalcemia.
223. MOA of ACE inhibitors?
a. Inhibit ACE, reducing levels of AG II and PREVENTING INACIVATION of bradykinin, a potent vasodilator.
b. Renin release is ↑ due to loss of feedback inhibition.
224. Clinical uses of ACE inhibitors?
a. HTN
b. CHF
c. Diabetic real disease.
225. Toxicity of ACE inhibitors?
a. Dry cough
b. Angioedema
c. Proteinuria
d. Taste changes
e. Hypotension
f. Pregnancy problems (fetal renal damage)
g. Rash
h. Increased renin
i. Lower angiotensin II.
j. Hyperkalemia!
226. When should you avoid ACE inhibitors?
a. Pregnancy
b. Hyperkalemia
c. Bilateral renal artery stenosis bc ACE inhibitors significantly ↓ GFR by preventing constriction of efferent arterioles.
227. Complete
227. Complete